Biomarkers Technologies, Markets and Companies Report 2018:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
438
Biomarkers Technologies, Markets and Companies Report 2018: Market Estimates for 2017-2027 with Profiles of 300+ Companies

Dublin, May 29, 2018 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century.

This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.

Currently the most important applications of biomarkers are in drug discovery and development. The role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described. Biomarkers are useful not only for diagnosis of some of these diseases but also for understanding the pathomechanism as well as a basis for development of therapeutics.

Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine.

Many of the regulatory issues concerning biomarkers are related to genomics, proteomics, molecular diagnostics and pharmacogenomics/pharmacogenetics. Validation of biomarkers and their role in clinical trials is discussed.

Biomarker markets are estimated from 2017 to 2027 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics. Market values are further split according to therapeutic applications and major geographical areas. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarker markets. Challenges facing the biomarker industry and strategies for developing biomarker markets are discussed.

A large number of companies with varying technical backgrounds are involved in biomarkers and 301 of these are profiled in part 2 of the report with classification into various categories.These also include major pharmaceutical companies. There is tabulation of 466 collaborations between companies and additional academic collaborations are mentioned in the individual profiles of companies. The report is supplemented by 910 references, 81 tables and 23 figures

Key Topics Covered:

Part 1: Technologies & Applications Executive Summary

1. Introduction

2. Technologies for Discovery of Biomarkers

3. Biomarkers and Molecular Diagnostics

4. Biomarkers for Drug Discovery & Development

5. Role of Biomarkers in Healthcare

6. Biomarkers in Metabolic Disorders

7. Biomarkers in Immune Disorders

8. Biomarkers of Musculoskeletal Disorders

9. Biomarkers of Infectious Diseases

10. Biomarkers of Genetic Disorders

11. Biomarkers of Aging

12. Nutritional Biomarkers

13. Biomarkers of Cancer 14. Biomarkers of Disorders of the Nervous System

15. Biomarkers of Cardiovascular Disorders

16. Biomarkers of Pulmonary Diseases

17. Biomarkers in Gynecology and Obstetrics

18. Biomarkers & Personalized Medicine

19. Biomarkers and Regulatory issues

20. References Part II: Markets & Companies 21. Markets for Biomarkers 22. Companies

For more information about this report visit https://www.researchandmarkets.com/research/t...rkers?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomarkers

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OSV Talks Launches New Season on Ministry Growth

Updated Category News Views 5

A Fresh Wave of Ideas for Catholic Ministry Some topics never go out of style, and it looks like the crew at OSV is banking on that with their latest salvo of OSV Talks. With themes ranging from peacemaking to AI, they're tossing it all against the spiritual wall, hoping it sticks. The comeback of their video series has that classic 'get your act together' vibe we all...

Continue Reading
Arbor Scientia Snags Second Consecutive BASA Win

Updated Category News Views 11

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

Continue Reading
Tax Strategy Crucial: Sidnell & Webster of Lufkin Weigh In

Updated Category News Views 3

Breaking Down Tax Prep vs. Planning Ever wonder why some folks never break a sweat come tax season, while others scramble like their hair's on fire? It all boils down to understanding two very different animals: tax preparation and tax planning. CPA veterans Yvette Sidnell and Jennifer Webster over in Lufkin, Texas, have laid it out crystal clear in their article with...

Continue Reading
Primoris Faces Allegations Over Misleading Project Costs

Updated Category News Views 6

Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....

Continue Reading
Jarrard Amplifies Healthcare Influence with D.C. Move

Updated Category News Views 5

Strategic Shift to the Heart of Policy When a healthcare advisory firm decides to root itself in the epicenter of American politics, you know they're gearing up for more than just casual conversation. Jarrard's leap into Washington, D.C. isn't just a relocation—it's an amplification of influence in the complex world of healthcare policy. This move, accentuated by the...

Continue Reading
Bryan Cranston Stars in Live Streaming 'A Christmas Carol'

Updated Category News Views 10

Cranston Climbs Into Scrooge's Shoes for a Cause If you think you've got the holiday season all figured out, add this curveball: Bryan Cranston as Ebenezer Scrooge, jawing through "A Christmas Carol" as part of a unique, one-night-only staged reading. And it's not just another star-studded ploy for attention. It's about rallying around a cause bigger than holiday cheer,...

Continue Reading
Shadeform Debuts Flex VMs, Revolutionizing GPU Utilization

Updated Category News Views 6

GPU Utilization Gets a New Spin with Flex VMs Folks, listen up: Shadeform just fired up something slick with its new Flex VMs. And, let me tell you, in today's market where GPU capacity is vanishing faster than free hotcakes on a Sunday morning, this might well be a game changer. Shadeform’s the name to remember, teaming up data center veterans with peeps who need to...

Continue Reading
New CEO at Simpli.fi: Sean McCaffrey Takes Charge

Updated Category News Views 17

A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...

Continue Reading
Hyliion Faces Legal Drama Over Securities Violations

Updated Category News Views 4

A Stock Tango Entangled in Legal Webs Ah, Hyliion Holdings Corp. (NYSE American: HYLN) finds itself in the legal crosshairs this time around. On October 20, 2026, DJS Law Group sounded the alarm, reminding investors that there’s a class action lawsuit hanging over Hyliion's head like a gray cloud over a picnic. Allegations of securities law violations are the game of...

Continue Reading
University of Phoenix Lowers Costs for Transfer Students

Updated Category News Views 7

The Pocket-Saving Game of Transfer Credits Here's the buzz: the University of Phoenix is putting some serious coin back into students' pockets through transfer credits. We're looking at more than $12,010 in savings per student, thanks to these policies, which is no chump change by any stretch. As over 900,000 credits were tossed into the pot, the savings side of education...

Continue Reading

Top 5 Most Recently Viewed Articles

Hive Digital Technologies Sees Growth in Hashrate and Revenue

Updated Category News Views 208

Exciting Updates from Hive Digital Technologies Hive Digital Technologies (NASDAQ: HIVE) shares have seen a boost in trading, reflecting positive developments in its hashrate and run-rate revenue. The surge in interest is attributed to the company's innovative strides in the cryptocurrency mining space. Hashrate Milestones Surpassed Recently, Hive made headlines by...

Continue Reading
Stride Inc. Addresses Market Concerns from Short Seller Claims

Updated Category News Views 57

Stride Inc. Stands Firm Against Short Seller Misinformation In light of recent unfounded claims circulating in the market, Stride, Inc. (NYSE: LRN) has made a strong statement against the misleading allegations from a known short seller, Fuzzy Panda Research. This self-designated short seller is positioned to benefit financially from a decline in Stride's stock price,...

Continue Reading
Key Economic Indicators and Fed Insights to Watch

Updated Category News Views 158

Pivotal Economic Events to Monitor As we approach crucial financial moments, it’s important to stay informed about the economic indicators and speeches that can impact market trends. While there are no major events on the calendar, several occurrences warrant attention. Insights from Federal Reserve On the horizon, one of the key highlights is the speech by Federal...

Continue Reading
Neuromorphic Computing Market Forecast: Growth Drivers and Trends

Updated Category News Views 127

Introduction to the Neuromorphic Computing Market The neuromorphic computing market is on the verge of significant expansion, with expectations to achieve a revenue of USD 55.6 billion by 2033, growing at a remarkable compound annual growth rate (CAGR) of 26.4%. This growth is attributed to the increasing development of computing systems that are modeled on the...

Continue Reading
Celebrating TEDA's 40 Years of Economic Advancement and Growth

Updated Category News Views 264

TEDA's 40-Year Journey of Transformation and Innovation TEDA, the Tianjin Economic-Technological Development Area, marks a significant milestone as it celebrates 40 years since its establishment. This remarkable area has undergone a transformative journey from a salt-alkali wasteland to one of the premier national-level economic development zones in the country. TEDA has...

Continue Reading